Helsinn support the Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award in Cancer Supportive Care whit research funding support for promising young physicians

4 May 2016

Helsinn Healthcare SA, The University of Texas MD Anderson Cancer Center enter strategic alliance to improve life of patients conducting clinical studies in cancer supportive and palliative care

26 April 2016

HELSINN GROUP SIGNS EXCLUSIVE AGREEMENT WITH PURDUE PHARMA CANADA FOR THE DISTRIBUTION AND LICENSING RIGHTS OF AKYNZEO® (NETUPITANT/PALONOSETRON combo) IN CANADA

26 April 2016

RIVOPHARM acquires HOLSTEN Pharma

13 April 2016

Helsinn announces publication of anamorelin ROMANA 1 and ROMANA 2 Phase III studies in The Lancet Oncology

24 March 2016

Helsinn presents Quality of Life, its first group sustainability report

24 March 2016

Helsinn and Eisai Announce Revised U.S. Collaboration for CINV Franchise

21 March 2016

Cerbios-Pharma SA Celebrating 40 Years of Biological activities

11 March 2016

HELSINN GROUP SIGNS EXCLUSIVE AGREEMENT WITH MUNDIPHARMA

25 February 2016

Cerbios’ new R&D Centre for HPAI and mAb development officially opened

23 February 2016